Narayana Hrudayalaya Q3 Review - Steady Performance Improvement In Tough Times: ICICI Direct 
Narayana Multispeciality clinic in Sarjapura (image: Company website)

Narayana Hrudayalaya Q3 Review - Steady Performance Improvement In Tough Times: ICICI Direct 

Bookmark

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Narayana Hrudayalaya Ltd.’s continued sequential recovery in financial performance amid the pandemic was significantly better than expected.

Revenues grew 24.9% QoQ to Rs 750 crore (down just 4.4% YoY) due to strong recovery seen across mature and new hospitals.

On the Ebitda front, margins have already exceeded Q3 FY20 levels by 90 basis points (up 953 bps QoQ) coming in at a robust 14.0% amid lower employee and other expenditure.

Subsequently, Ebitda grew 2.2%, 292.1% YoY, QoQ to Rs 105 crore.

Click on the attachment to read the full report:

ICICI Direct Narayana Hrudayalaya Q3FY21 Result update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.